celgene

  1. Financial impact of stopping Crohn's disease trials

    Mongersen drug was bought by Celgene for $710 million four years ago. Yesterday, Celgene announced that Mongersen had failed and it is going to halt the trials. But to SEC they have given the details of the financial impact in connection with the decision of stopping these trials...
    • anonymous
    • Thread
    • celgene crohn's disease trial
    • Replies: 1
    • Forum: Celgene

  2. Major blow for Celgene

    Celgene to stop the two trials for Crohn's disease and will not start the third trial as per the recommendation from Data Monitoring Committee. http://alph.st/b5c024f0
    • anonymous
    • Thread
    • celgene crohn's disease trial
    • Replies: 3
    • Forum: Celgene

  3. Celgene and Acceleron amend agreement

    Celgene to receive royalties on global net sales in the pulmonary hypertension field.
    • anonymous
    • Thread
    • agreement celgene
    • Replies: 0
    • Forum: Celgene

  4. Celgene to present data in ESMO 2017

    Celgene presenting data for Abraxane at ESMO 2017.
    • anonymous
    • Thread
    • cancer treatment celgene oncology
    • Replies: 0
    • Forum: Celgene

  5. FDA halts Celgene

    Celgene forced to pause 5 trials using AstraZeneca’s Imfinzi and full hold on one trial.
    • anonymous
    • Thread
    • cancer treatment celgene drugs fda
    • Replies: 0
    • Forum: Celgene

  6. Any interview tips for Summit?

    Have an interview coming up at the Summit site, any advice would be greatly appreciated.
    • anonymous
    • Thread
    • celgene interview advice
    • Replies: 5
    • Forum: Celgene
Top Bottom
Back